INTERNATIONAL PATENT: SUMITOMO PHARMA AMERICA, INC. FILES APPLICATION FOR "METHODS OF ADMINISTERING THE NEUROPSYCHIATRIC MEDICATION ULOTARONT BASED ON RENAL IMPAIRMENT"

GENEVA, Aug. 26 -- SUMITOMO PHARMA AMERICA, INC. (84 Waterford DriveMarlborough, Massachusetts 01752) filed a patent application (PCT/US2025/015881) for "METHODS OF ADMINISTERING THE NEUROPSYCHIATRIC MEDICATION ULOTARONT BASED ON RENAL IMPAIRMENT" on Feb 14, 2025. With publication no. WO/2025/175067, the details related to the patent application was published on Aug 21, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): HOPKINS, Seth Cabot (c/o Sumitomo Pharma America, Inc.84 Waterford DriveMarlborough, Massachusetts 01752), GALLUPPI, Gerald R. (c/o Sumitomo Pharma America, Inc.84 Waterford Dri...